Literature DB >> 9246335

Rapid neurological deterioration in a 22-year-old man.

M O McCarron1, G V McDonnell, J M Gibson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246335      PMCID: PMC2431354          DOI: 10.1136/pgmj.73.860.344

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.

Authors:  C Miller; C P Farrington; K Harbert
Journal:  Int J Epidemiol       Date:  1992-10       Impact factor: 7.196

2.  Subacute sclerosing panencephalitis in England and Wales: transient effects and risk estimates.

Authors:  C P Farrington
Journal:  Stat Med       Date:  1991-11       Impact factor: 2.373

Review 3.  The prognosis of subacute sclerosing panencephalitis in adults. Report of 8 cases and review of the literature.

Authors:  E Tan; I J Namer; A Ciger; T Zileli; T Kucukali
Journal:  Clin Neurol Neurosurg       Date:  1991       Impact factor: 1.876

4.  Revaccination against measles and rubella.

Authors:  F T Cutts
Journal:  BMJ       Date:  1996-03-09

5.  Subacute sclerosing panencephalitis in Wales.

Authors:  J Sussman; D A Compston
Journal:  Q J Med       Date:  1994-01

6.  Surveillance of subacute sclerosing panencephalitis.

Authors:  M H Bellman; G Dick
Journal:  Br Med J       Date:  1980-08-02

7.  Chronological SPECT studies of a patient with subacute sclerosing panencephalitis.

Authors:  S Yagi; Y Miura; S Mizuta; A Wakunami; N Kataoka; T Morita; K Morita; S Ono; M Fukunaga
Journal:  Brain Dev       Date:  1993 Mar-Apr       Impact factor: 1.961

8.  Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.

Authors:  G Gascon; S Yamani; J Crowell; B Stigsby; M Nester; I Kanaan; A Jallu
Journal:  Brain Dev       Date:  1993 Sep-Oct       Impact factor: 1.961

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.